In June 2024, the Saudi Food and Drug Authority (SFDA) identified six pharmacies for failing to provide registered pharmaceutical preparations to the local market, report drug movements in the electronic tracking system, or inform the SFDA of expected shortages or interruptions in the supply of registered preparations.
The Saudi Food and Drug Authority (SFDA) seized 571 unlicensed facilities engaged in the manufacture and storage of food, medicines, and medical devices in the regions of Makkah and Madinah, referring the violating establishments to the competent authorities for legal action.
The SFDA explained that it conducted 3,676 inspection visits to the facilities under its supervision during intensive supervisory tours as part of its role during the Hajj season, ensuring the safety of food, medicines, and medical products.
The Saudi Food and Drug Authority (SFDA) detected 187 violating facilities and 277 types of products during 1,959 monitoring and inspection tours conducted across all regions of the Kingdom in May 2024.
The third meeting of the Heads of National Medicines Regulatory Authorities (NMRAs) of the Organization of Islamic Cooperation (OIC) Member States concluded today. Held in Riyadh from December 17-18, the meeting was chaired by H.E. Dr. Hisham S. Aljadhey, CEO of the Saudi Food and Drug Authority (SFDA).
The Kingdom of Saudi Arabia, represented by the Saudi Food and Drug Authority (SFDA), hosted the third meeting of the Heads of National Medicines Regulatory Authorities (NMRAs) of the Organization of Islamic Cooperation (OIC) Member States today, December 17-18, in Riyadh. The two-day event focused on the theme "Advancing Medicine Regulation and R&D Ecosystems: Pathways to Regulatory Maturity."
The Kingdom of Saudi Arabia, represented by the Saudi Food and Drug Authority (SFDA), in collaboration with the Organization of Islamic Cooperation (OIC), is hosting the third meeting of the Heads of National Medicines Regulatory Authorities (NMRAs) of OIC Member States. Under the theme “Advancing Medicine Regulation and R&D Ecosystems: Pathways to Regulatory Maturity,” the meeting will take place on December 17-18 at the SFDA headquarters in Riyadh.
The Saudi Food and Drug Authority (SFDA) is participating in the global pharmaceutical exhibition, the Convention on Pharmaceutical Ingredients (CPHI) Middle East, sponsored and supported by the Saudi Ministry of Health. The event will be held at the Riyadh Exhibition and Convention Center from December 10 to 12, 2024, featuring participation from over 100 countries, 150 speakers, and 400 exhibitors representing major local and international pharmaceutical companies.
The Saudi Food and Drug Authority (SFDA) registered more than 469 applications through the Saudi Drug Registration (SDR) System during the first half of 2024. Additionally, over 100 products were registered, and the number of certificates issued in the system exceeded 416.
